CKD represents a major post-operative long-term complication in renal surgery for renal cell cancer (RCC). This is the case both for radical and partial nephrectomy and despite major advances in surgical techniques. Whether the renal hyperfiltration mechanism after an acute loss of nephron mass could promote a compensatory process over time in oncological patients is still under debate. Therefore, a retrospective study by Prof. Francesco Trevisani (IRCCS Ospedale San Raffaele, Milan, Italy) and colleagues compared the eGFR decay at different time points in patients who underwent radical (n=153) or partial nephrectomy (n=118). eGFR was evaluated prior to surgery, at hospital dismissal, and at 6, 12, 24, 36, 48, and 60 months of follow-up. Included patients had normal renal function at baseline.
Median basal eGFR was 92.3 mL/min/1.73m2 for radical nephrectomy and 95.4 mL/min/1.73m2 for partial nephrectomy (P=0.01). Most patients were men, with a men-women ratio of 3.2 for radical nephrectomy and 1.8 for partial nephrectomy (P=0.04). CKD class differed between radical nephrectomy (class I in 64% and class II in 36%) and partial nephrectomy (class I in 76% and class II in 24%; P=0.03). The results demonstrated that eGFR decreased significantly more in the radical nephrectomy group versus the partial nephrectomy group (P<0.001 for all timepoints), but that the radical nephrectomy patients tend to improve their eGFR over time.
A prospective comparison multicentre study with living kidney donors is ongoing.
- Trevisani F. Renal functional outcomes at 5 years from radical and partial nephrectomies in normal renal function patients: An untold story of failed hyperfiltrations. P0623, EAU21 Virtual, 8–12 July 2021.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Best of EAU: Highlights on bladder cancer Next Article
PSMA PET-CT more accurate than standard-of-care imaging in RCC »
« Best of EAU: Highlights on bladder cancer Next Article
PSMA PET-CT more accurate than standard-of-care imaging in RCC »
Table of Contents: EAU 2021
Featured articles
EAU TV: Robotic surgery and advanced prostate cancer
LUTS & BPH
Best of EAU: The surgical armamentarium is evolving
IPSS: Visual alternatives to aid comprehension and new risk prediction models
Urinary Tract Infections
Prophylactic treatments for recurrent urinary tract infections
Failure of conservative management in emphysematous pyelonephritis
Antibiotic treatment of healthcare-associated infections
Prostate Cancer
EAU TV: Robotic surgery and advanced prostate cancer
EAU TV: The best on prostate cancer and incontinence & andrology
Best of EAU: Updates on imaging and treatment of prostate cancer
Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC
177Lu-PSMA-617: A new class of effective therapy
Testis and Penile Cancer
Best of EAU: New advances in testicular and penile cancer
Recommendations for the management of indeterminate small testis masses
Residual tumour resection in case of elevated markers
Bladder Cancer
Best of EAU: Highlights on bladder cancer
ctDNA can guide adjuvant immunotherapy in muscle-invasive bladder cancer
Durvalumab ± tremelimumab by cisplatin eligibility in metastatic urothelial carcinoma
Circulating tumour cells could aid in the decision to give neoadjuvant chemotherapy
Renal Cancer
Best of EAU: Immune cell populations have prognostic value in RCC
KEYNOTE-564: First positive phase 3 results with adjuvant checkpoint inhibition in RCC
PSMA PET-CT more accurate than standard-of-care imaging in RCC
Worse renal function after radical versus partial nephrectomy
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com